Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

Hormone therapy resistance and the ensuing aggressive tumor progression present a significant clinical challenge. However, the mechanisms underlying the induction of tumor malignancy upon inhibition ...

They are very rare. Structures around the eye include the eyelids and tear glands (lacrimal glands). They are called adnexal structures. So doctors call cancers that develop in these tissues adnexal ...

Thymus cancer. This rare type of cancer grows in cells of the thymus gland. It can spread to other parts of your body. Thymic involution. The thymus gland slowly shrinks as you get older.

Researchers have developed an AI-powered model that—in 10 seconds—can determine during surgery if any part of a cancerous brain tumor that could be removed remains, a study published in Nature ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied ...

A retrospective study, however, suggests the thymus gland is not nearly as expendable as experts once thought. US researchers found that those who get their thymus removed face an increased risk of ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

After a routine ultrasound at 24 weeks, Brailey and Louis Valenzuela learned some unexpected news about their baby, Arley — she had an olive-sized tumor on her heart known as pericardial ...

Gland Pharma (Rs 1,822, +13.1%) The stock surged on positive brokerage views despite weak Q2 results. Bull case: Sharp stock underperformance in 2024 so far leaves little room for more downside ...